Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
AssigneeSalix Pharmaceuticals, Inc.
InventorsDoug Bettenhausen, Christopher Jahraus
Life of this patent
Estimating the term…
Loading patent…
AssigneeSalix Pharmaceuticals, Inc.
InventorsDoug Bettenhausen, Christopher Jahraus
Estimating the term…
The present invention provides a new method of ameliorating and/or treating enteritis induced by radiation therapy, alone or in combination with other therapies, for the treatment of, for example, gastrointestinal malignancies, including colorectal, appendiceal, anal, or small bowel cancers; urogenital malignancies, including prostate, ladder, testicular, or penile cancers; gynecologic malignancies, including cervical, endometrial, ovarian, vaginal, or vulvar cancers; or osteogenic and other sarcomatous malignancies in which pelvic structures are involved, comprising the administration of a therapeutically effective amount of balsalazide to a patient in need thereof.
A method of treating radiation induced enteritis comprising, administering to a subject in need thereof a therapeutically effective amount of balsalazide.
A method of protecting against radiation induced enteritis comprising, administering to a subject before, during, and/or after undergoing radiation therapy a therapeutically effective amount of balsalazide.
A method of protecting against radiation induced injury to the mucosa of the colon comprising, administering to a subject before, during, and/or after undergoing radiation therapy a therapeutically effective amount of balsalazide.
A method of protecting against radiation induced colorectal inflammation comprising, administering to a subject before, during, and/or after undergoing radiation therapy a therapeutically effective amount of balsalazide.
Dependencies are inferred from the claim text.